Your browser doesn't support javascript.
loading
MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer.
Chen, Ai-Hua; Qin, Yu-E; Tang, Wen-Fan; Tao, Jing; Song, Hua-Mei; Zuo, Manzhen.
Afiliación
  • Chen AH; Department of Gynecology and Obstetrics, The People's Hospital of China, China Three Gorges University, The First People's Hospital of Yichang, Yichang, Hubei 443000 China.
  • Qin YE; Department of Gynecology and Obstetrics, The People's Hospital of China, China Three Gorges University, The First People's Hospital of Yichang, Yichang, Hubei 443000 China.
  • Tang WF; Department of Gynecology and Obstetrics, The People's Hospital of China, China Three Gorges University, The First People's Hospital of Yichang, Yichang, Hubei 443000 China.
  • Tao J; Department of Gynecology and Obstetrics, The People's Hospital of China, China Three Gorges University, The First People's Hospital of Yichang, Yichang, Hubei 443000 China.
  • Song HM; Department of Gynecology and Obstetrics, The People's Hospital of China, China Three Gorges University, The First People's Hospital of Yichang, Yichang, Hubei 443000 China.
  • Zuo M; Department of Gynecology and Obstetrics, The People's Hospital of China, China Three Gorges University, The First People's Hospital of Yichang, Yichang, Hubei 443000 China.
Cancer Cell Int ; 17: 63, 2017.
Article en En | MEDLINE | ID: mdl-28615991

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Cell Int Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Cell Int Año: 2017 Tipo del documento: Article